Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …

The natural history of chronic Hepatitis C Virus (HCV) infection is still poorly understood. The
main reason is the asymptomatic onset and course in the majority of infected subjects …

There has long been evidence that hepatitis C can lead to persistent infection in a high
proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and …

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and
hepatocellular carcinoma, as well as the most common indication for liver transplantation in …

Hepatitis C virus (HCV) infection remains a major global health burden. Hepatitis C causes
significant liver-related morbidity and mortality due to hepatic decompensation and …

Hepatitis C virus (HCV) affects 130-210 million people worldwide and is one of the major
risk factors for hepatocellular carcinoma. Globally, at least one third of hepatocellular …

Hepatitis C is a heterogeneous disease and is responsible for considerable mortality and
morbidity. The hepatitis C virus (HCV) infects nearly 170 million people world-wide. More …

Hepatitis C virus (HCV) is the most common cause of chronic liver disease, cirrhosis, and
hepatocellular carcinoma (HCC) in the United States and infects an estimated 170 million …

Hepatitis C virus (HCV) currently infects an estimated 2-3 million people in the United States
and 175 million people globally. Over 80% of infected patients go on to develop chronic …

Background The prevalence of hepatitis C virus (HCV) infection in the United States has
remained constant from 1988 through 2002, although the peak age of infection has …